Epigenomics Ag
Patents = 68
Trademarks = 5
Forward Citations = 455
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
125 inventors (with patents filed for the assignee):
Epigenomics AG is a molecular diagnostics company focused on developing and commercializing innovative products for cancer diagnosis. They specialize in the development and implementation of blood-based tests for early cancer detection, prognosis, and personalized treatment. With a strong focus on epigenetic biomarkers, Epigenomics aims to improve patient outcomes by providing accurate, reliable, and non-invasive diagnostic solutions. For more information, visit their website.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com